Rhabdomyolysis due to simvastatin in a transplant patient: Are some statins safer than others? [7]

Nephrology Dialysis Transplantation

Volumn 16, Issue 4, 2001, Pages 873-874

  Stirling, Catherine M ^a   Isles, Christopher G ^a  

^a DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; CERIVASTATIN; CLARITHROMYCIN; CYCLOSPORIN; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; ERYTHROMYCIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ITRACONAZOLE; MEVINOLIN; PRAVASTATIN; PREDNISOLONE; SIMVASTATIN;

ADULT; CADAVER KIDNEY; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; DIALYSIS; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SAFETY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LETTER; MYOPATHY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RHABDOMYOLYSIS;

ANTILIPEMIC AGENTS; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; RHABDOMYOLYSIS; SIMVASTATIN;

EID: 0035086850     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.4.873     Document Type: Letter

References (5)

1. Drug interactions of lipid altering drugs
2. Increase in Cerivastatin systemic exposure after single and multiple dosing in cyclosporin treated kidney transplant patients
3. Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl/Coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar?
4. Practical statin prescribing
5. Effect of pravastatin on outcomes after cardiac transplantation